Aurinia Pharmaceuticals CEO Buys $12.5 Million Worth of Shares

MT Newswires Live06-03

Aurinia Pharmaceuticals (AUPH) Chief Executive Kevin Tang purchased about 815,000 shares in the company for a combined $12.5 million, a Wednesday filing with the US Securities and Exchange Commission showed.

Shares were acquired between May 29 and June 2 across several transactions at prices ranging from $15.28 to $15.35 apiece, the filing showed.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment